March 23, 2018
A Delaware federal judge on Thursday found Alvogen Pine Brook Inc. didn't infringe two patents tied to the opioid addiction treatment Suboxone, shooting down a challenge by Indivior Inc. and Aquestive Therapeutics that culminated in a September bench trial.